165 related articles for article (PubMed ID: 30061281)
1. Single-Center Pharmacokinetic Study and Simulation of a Low Meropenem Concentration in Brain-Dead Organ Donors.
Lee JM; Lee JW; Jeong TS; Bang ES; Kim SH
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061281
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetic Analysis of Meropenem After Intravenous Infusion in Korean Patients With Acute Infections.
Kim YK; Lee DH; Jeon J; Jang HJ; Kim HK; Jin K; Lim SN; Lee SS; Park BS; Kim YW; Shin JG; Kiem S
Clin Ther; 2018 Aug; 40(8):1384-1395. PubMed ID: 30093133
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation.
O'Jeanson A; Larcher R; Le Souder C; Djebli N; Khier S
Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):695-705. PubMed ID: 34403127
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic analysis of meropenem, by Monte Carlo simulation, in both plasma and cerebrospinal fluid in patients with cerebral hemorrhage after external ventricular drainage
.
Kong L; Xu H; Wu C; Kong X; Yu M; Shi Q; Wu X
Int J Clin Pharmacol Ther; 2020 Jan; 58(1):50-56. PubMed ID: 31670654
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two empirical prolonged infusion dosing regimens for meropenem in patients with septic shock: A two-center pilot study.
Eisert A; Lanckohr C; Frey J; Frey O; Wicha SG; Horn D; Ellger B; Schuerholz T; Marx G; Simon TP
Int J Antimicrob Agents; 2021 Mar; 57(3):106289. PubMed ID: 33515688
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment?
Corcione S; D'Avolio A; Loia RC; Pensa A; Segala FV; De Nicolò A; Fatiguso G; Romeo M; Di Perri G; Stella M; De Rosa FG
J Glob Antimicrob Resist; 2020 Mar; 20():22-27. PubMed ID: 31207380
[TBL] [Abstract][Full Text] [Related]
7. Plasma and synovial fluid pharmacokinetics of a single intravenous dose of meropenem in adult horses.
Langston VC; Fontenot RL; Byers JA; Andrews CM; Mochal-King CA
J Vet Pharmacol Ther; 2019 Sep; 42(5):525-529. PubMed ID: 31222751
[TBL] [Abstract][Full Text] [Related]
8. Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients.
Busse D; Simon P; Schmitt L; Petroff D; Dorn C; Dietrich A; Zeitlinger M; Huisinga W; Michelet R; Wrigge H; Kloft C
Clin Pharmacokinet; 2022 May; 61(5):655-672. PubMed ID: 34894344
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
Pai MP; Cojutti P; Pea F
Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
[TBL] [Abstract][Full Text] [Related]
10. The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose.
Tamatsukuri T; Ohbayashi M; Kohyama N; Kobayashi Y; Yamamoto T; Fukuda K; Nakamura S; Miyake Y; Dohi K; Kogo M
J Infect Chemother; 2018 Oct; 24(10):834-840. PubMed ID: 30087007
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a non-parametric modelling for meropenem in critically ill patients using Monte Carlo simulation.
Idoate Grijalba AI; Aldaz Pastor A; Marquet P; Woillard JB
Eur J Clin Pharmacol; 2019 Oct; 75(10):1405-1414. PubMed ID: 31338539
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive care units.
Jaruratanasirikul S; Thengyai S; Wongpoowarak W; Wattanavijitkul T; Tangkitwanitjaroen K; Sukarnjanaset W; Jullangkoon M; Samaeng M
Antimicrob Agents Chemother; 2015; 59(6):2995-3001. PubMed ID: 25753628
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.
Wittau M; Scheele J; Kurlbaum M; Brockschmidt C; Wolf AM; Hemper E; Henne-Bruns D; Bulitta JB
Antimicrob Agents Chemother; 2015 Oct; 59(10):6241-7. PubMed ID: 26248353
[TBL] [Abstract][Full Text] [Related]
14. Changes of PK/PD of Meropenem in patients with abdominal septic shock and exploration of clinical rational administration plan: a prospective exploratory study.
Wang Y; Li H; Wang D; Li Y; Shen Y; Fu Y; Li Y; Gao M; Zhang D
Sci Rep; 2024 May; 14(1):10173. PubMed ID: 38702351
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetic Model and Dosing Simulation of Meropenem Using Measured Creatinine Clearance for Patients with Sepsis.
Fukumoto S; Ohbayashi M; Okada A; Kohyama N; Tamatsukuri T; Inoue H; Kato A; Kotani T; Sagara H; Dohi K; Kogo M
Ther Drug Monit; 2023 Jun; 45(3):392-399. PubMed ID: 36253888
[TBL] [Abstract][Full Text] [Related]
16. What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling.
Delattre IK; Hites M; Laterre PF; Dugernier T; Spapen H; Wallemacq PE; Jacobs F; Taccone FS
Int J Antimicrob Agents; 2020 Oct; 56(4):106113. PubMed ID: 32721604
[TBL] [Abstract][Full Text] [Related]
17. Optimized meropenem dosage regimens using a pharmacokinetic/pharmacodynamic population approach in patients undergoing continuous venovenous haemodiafiltration with high-adsorbent membrane.
Padullés Zamora A; Juvany Roig R; Leiva Badosa E; Sabater Riera J; Pérez Fernández XL; Cárdenas Campos P; Rigo Bonin R; Alía Ramos P; Tubau Quintano F; Sospedra Martinez E; Colom Codina H
J Antimicrob Chemother; 2019 Oct; 74(10):2979-2983. PubMed ID: 31335959
[TBL] [Abstract][Full Text] [Related]
18. Meropenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy.
Chaijamorn W; Rungkitwattanakul D; Pattharachayakul S; Singhan W; Charoensareerat T; Srisawat N
J Crit Care; 2020 Dec; 60():285-289. PubMed ID: 32949895
[TBL] [Abstract][Full Text] [Related]
19. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
Esteve-Pitarch E; Padullés-Zamora A; Maisterra-Santos K; Colom-Codina H; Cobo-Sacristán S
Farm Hosp; 2019 Sep; 43(5):151-157. PubMed ID: 31469627
[TBL] [Abstract][Full Text] [Related]
20. Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center Study.
Kumta N; Heffernan AJ; Cotta MO; Wallis SC; Livermore A; Starr T; Wong WT; Joynt GM; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0014222. PubMed ID: 35862757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
